Fusidic acid plus betamethasone in infected or potentially infected eczema

Pharmatherapeutica. 1985;4(2):126-31.

Abstract

Eighty-one patients with atopic dermatitis and contact dermatitis received a 1-week treatment with 0.1% betamethasone alone on one side and 0.1% betamethasone plus 2% fusidic acid on the other side. Clinically, the combination was marginally superior and in patient preference a significant difference in favour of the combination was recorded. Bacteriologically, the combination eliminated 67% of bacteria originally present in the skin lesions compared with 51% with steroid alone.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Betamethasone / administration & dosage
  • Betamethasone / adverse effects
  • Betamethasone / therapeutic use*
  • Clinical Trials as Topic
  • Double-Blind Method
  • Drug Resistance, Microbial
  • Drug Therapy, Combination
  • Eczema / complications
  • Eczema / drug therapy*
  • Eczema / microbiology
  • Female
  • Fusidic Acid / administration & dosage
  • Fusidic Acid / adverse effects
  • Fusidic Acid / therapeutic use*
  • Humans
  • Male
  • Middle Aged
  • Random Allocation
  • Skin Diseases, Infectious / drug therapy*
  • Skin Diseases, Infectious / etiology
  • Staphylococcal Infections / drug therapy

Substances

  • Fusidic Acid
  • Betamethasone